Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Meeting

Summary

Jazz Pharmaceuticals will present six abstracts on Epidiolex and Xywav at the 2026 American Academy of Neurology Annual Meeting, including one oral presentation demonstrating real-world evidence in rare neurological disorders.